Oseltamivir removed from the WHO Essential Medicines List. A convenient decision?
Keywords:
Oseltamivir, Orthomyxoviridae, Antiviral AgentsAbstract
No abstract
Downloads
References
Organización Mundial de la Salud (OMS). La OMS actualiza la Lista de Medicamentos Esenciales. Ginebra: OMS; 6 de junio de 2017. Disponible en http://www.who.int/mediacentre/news/releases/2017/essential-medicines-list/es/ [Consultado el 20 de agosto de 2017].
Ebell MH, Call M, Shinholser J. Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract. 2013 Apr;30(2):125-33. doi: 10.1093/fampra/cms059.
World Health Organization (WHO). Antiviral drugs for pandemic (H1N1) 2009: definitions and use. WHO; 22 december 2009. Disponible en http://www.who.int/csr/disease/swineflu/frequently_asked_questions/antivirals/definitions_use/en/ [Consultado el 21 de agosto de 2017].
Wang CB, Chiu ML, Lin PC, Liang WM, Chen CY, Chang YJ, et al. Prompt Oseltamivir Therapy Reduces Medical Care and Mortality for Patients With Influenza Infection: An Asian Population Cohort Study. Medicine (Baltimore). 2015 Jul;94(27):e1070
World Health Organization (WHO). Members of the 21st Expert Committee on the Selection and Use of Essential Medicines. Disponible en http://www.who.int/selection_medicines/committees/expert/21/experts/members-21stcommittee/en/ [Consultado el 22 de agosto de 2017].
Downloads
Published
Issue
Section
License
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.
